<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01229917</url>
  </required_header>
  <id_info>
    <org_study_id>Valio-73</org_study_id>
    <nct_id>NCT01229917</nct_id>
  </id_info>
  <brief_title>Rhinovirus Study With Lactobacillus Rhamnosus GG</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Valio Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Helsinki University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Virginia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medcare Ltd</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Valio Ltd</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the symptom impact of probiotic Lactobacillus
      rhamnosus GG during rhinovirus infection.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <condition>Respiratory Tract Infections [C08.730]</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fruit juice with Lactobacillus rhamnosus GG, version 1</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fruit juice with Lactobacillus rhamnosus GG, version 2</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard fruit juice</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female in general good health (stabilized chronic illnesses and regular
             medications are accepted, if not otherwise mentioned in the exclusion criteria)

          2. Age 18-65 years

          3. Serum neutralizing antibody titer of 1:4 or less for the challenge rhinovirus

          4. No clinically significant finding on the pre-study nasal examination

          5. Females must have a negative urine pregnancy test, and women of child-bearing
             potential must be using an effective method of birth control such as, but not limited
             to birth control pills, contraceptive foam, diaphragm, IUD, surgical sterilization,
             abstinence, or condoms

          6. Written informed consent must be obtained at enrollment into the study

        Exclusion Criteria:

          1. Suffer from or have a history of significant allergic rhinitis at the time of study

          2. Bronchial asthma or other lower respiratory tract diseases, such as chronic
             obstructive lung disease or emphysema

          3. Nasal abnormalities or other nasal pathology, such as irreversible nasal mucosal
             hypertrophy or severe nasal septum derivation

          4. Pregnancy or lactation

          5. History of alcohol abuse (regularly consumes 5 or more alcohol drinks per day) and/or
             drug abuse during the 12 month period immediately preceding study enrollment

          6. Daily smoking within the past 2 years

          7. Use of investigational product or participation in a device trial during the 30 day
             period immediately preceding study enrollment

          8. Previous participation in an experimental study with rhinovirus 39

          9. Allergy to any ingredient in the study product

         10. Have, as determined by the investigator and/or the sponsor's medical monitor, any
             surgical or medical condition or take any medication or dietary supplement that could
             interfere with the interpretation of study results or jeopardize the safety of the
             subject
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Birgit Winther, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Virginia Health System</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Virginia, Respiratory Disease Study Center</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 26, 2010</study_first_submitted>
  <study_first_submitted_qc>October 26, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 28, 2010</study_first_posted>
  <last_update_submitted>July 6, 2011</last_update_submitted>
  <last_update_submitted_qc>July 6, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 7, 2011</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Tract Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

